mRNA-.

Yoshino Kawaguchi1,2, Mari Kimura1,3, Tatsuya Karaki1,3

  • 1Vaccine Creation Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Research Institute for Microbial Diseases, The University of Osaka, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.

ACS nano
|July 23, 2025
PubMed
概括

修改mRNA疫苗中的脂质纳米粒子 (LNP) 组件,如PEG脂质和脂质,可以增强免疫反应,同时减少发烧等副作用. 这种优化可以提高疫苗的疗效和耐受性.